Travis Nemkov, PhD is focused on developing innovative technologies and working with start-up companies for their commercialization. Immediately following graduation from the University of Colorado at Boulder, Travis continued work on his undergraduate thesis as part of a new spin-out company, AmideBio. As the company’s first employee, he helped establish operations and developed foundational technologies for the production of therapeutic peptides with high purity and yield at low cost. He then moved to the University of Colorado Anschutz Medical Campus for his Doctorate in Structural Biology and Biochemistry, where he developed high-throughput omics tools to study systems-wide metabolism. In addition to his own research as a Postdoctoral Fellow at UC Anschutz, Travis co-founded Omix Technologies with other faculty members to provide these tools for companies in multiple areas, including the regenerative medicine, transfusion medicine, biofuel, and pharmaceutical industries. He is an author on over 80 publications and 2 patents.